Green Lifescience Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	10,479	9,068	6,348	2,814	3,388	2,402
Short-Term Investments	55.38	127.56	5,669	2,300	7,800	7,800
Trading Asset Securities	3,766	3,690	2,436	11,835	5,015	4,930
Cash & Short-Term Investments	14,300	12,885	14,453	16,949	16,203	15,133
Cash Growth	5.52%	-10.85%	-14.73%	4.60%	7.08%	-26.21%
Accounts Receivable	7,069	4,997	1,451	2,509	3,450	1,753
Other Receivables	67.44	38.99	8.54	333.75	114.13	284.56
Receivables	7,136	5,036	1,460	2,843	3,564	2,037
Inventory	5,367	3,905	5,311	6,014	5,732	6,649
Prepaid Expenses	52.07	52.01	160.15	42.62	735.77	438.83
Other Current Assets	102.04	112.3	328.73	595.04	657.55	314.22
Total Current Assets	26,958	21,991	21,712	26,443	26,892	24,572
Property, Plant & Equipment	13,627	13,533	13,256	27,112	36,846	35,626
Long-Term Investments	-	-	-	-	7,381	9,912
Other Intangible Assets	340.87	97.47	2.81	87.92	181.72	370.26
Long-Term Deferred Tax Assets	-	-	-	-	619.37	355.14
Long-Term Deferred Charges	58.68	11.92	24.91	-	-	-
Other Long-Term Assets	9,359	9,339	8,833	8,788	57.44	12.08
Total Assets	50,343	44,972	43,828	62,432	71,977	70,846
Accounts Payable	5,988	-	-	-	4,114	2,835
Accrued Expenses	174.28	-	-	-	2.12	136.07
Short-Term Debt	6,600	4,800	4,800	6,488	7,433	6,211
Current Portion of Leases	149.76	41.01	104.04	117.85	104.86	170.18
Current Unearned Revenue	28.7	46.72	34	34	-	-
Other Current Liabilities	1,249	3,426	2,455	2,796	3,588	1,429
Total Current Liabilities	14,190	8,314	7,394	9,437	15,242	10,781
Long-Term Leases	453.15	530.9	28.82	18.27	57.76	31.42
Pension & Post-Retirement Benefits	538.33	357.51	443.95	331.2	371.39	656.15
Other Long-Term Liabilities	34.12	21.61	8.12	6.78	8.19	6.67
Total Liabilities	15,215	9,224	7,874	9,793	15,679	11,475
Common Stock	10,000	10,000	10,000	7,500	7,500	7,500
Additional Paid-In Capital	15,025	15,025	36,425	38,956	38,956	38,956
Retained Earnings	12,126	12,746	-10,105	6,232	9,680	12,820
Treasury Stock	-2,023	-2,023	-366.29	-	-	-
Comprehensive Income & Other	-0	-0	0	-48.7	162.39	95.97
Shareholders' Equity	35,128	35,748	35,954	52,639	56,298	59,371
Total Liabilities & Equity	50,343	44,972	43,828	62,432	71,977	70,846
Total Debt	7,203	5,372	4,933	6,624	7,595	6,413
Net Cash (Debt)	7,097	7,513	9,520	10,324	8,608	8,720
Net Cash Growth	-16.98%	-21.08%	-7.79%	19.93%	-1.28%	-42.80%
Net Cash Per Share	371.83	390.48	476.93	516.22	430.42	436.01
Filing Date Shares Outstanding	19.09	19.09	19.83	20	20	20
Total Common Shares Outstanding	19.09	19.09	19.83	20	20	20
Working Capital	12,768	13,677	14,319	17,007	11,651	13,791
Book Value Per Share	1840.38	1872.83	1812.66	2631.95	2814.92	2968.56
Tangible Book Value	34,787	35,650	35,951	52,551	56,117	59,001
Tangible Book Value Per Share	1822.52	1867.72	1812.52	2627.55	2805.83	2950.04
Land	8,450	8,450	8,425	8,329	7,923	7,923
Buildings	7,918	7,918	7,846	16,077	13,381	13,381
Machinery	36,049	35,677	35,434	38,766	39,913	37,596
Construction In Progress	117.88	-	23.1	207.03	11,769	10,758

Source: S&P Global Market Intelligence. Standard template. Financial Sources.